FDA Import Policy Discourages Promotion, Not Reimbursement – McClellan

FDA's letter to health insurers about drug importation is meant to ensure they do not encourage policy holders to purchase drugs from outside the U.S., not to prohibit them from covering individuals who purchase Canadian drugs for personal use, FDA Commissioner McClellan told a Senate Appropriations/Agriculture Subcommittee hearing May 22